Category: 3. Business

  • Trump hits out at Goldman Sachs chief over ‘bad’ tariff prediction | Trump tariffs

    Trump hits out at Goldman Sachs chief over ‘bad’ tariff prediction | Trump tariffs

    Donald Trump hit out at Goldman Sachs CEO David Solomon on Tuesday, saying the bank had been wrong to predict tariffs would hurt the economy and questioning whether Solomon should lead the Wall Street institution.

    In a post on Truth Social, Trump said it was mostly foreign companies and governments absorbing the cost of his tariffs. “But David Solomon and Goldman Sachs refuse to give credit where credit is due. They made a bad prediction…on both the Market repercussion and the Tariffs themselves,” he wrote.

    Trump said Solomon should maybe focus on being a DJ, a hobby Solomon abandoned some time ago, “and not bother running a major Financial Institution”.

    The bank CEO is the latest corporate boss to become the target of Trump’s ire.

    A Goldman Sachs spokesperson declined to comment. A spokesperson for the White House did not immediately respond to a request for comment.

    Since 1 February, when Trump kicked off trade wars by slapping levies on imports from Mexico, Canada and China, at least 333 companies worldwide have reacted to the tariffs in some manner, as of Tuesday, according to a Reuters tracker.

    While Trump did not specify which Goldman research he was referring to, the Wall Street bank – like many of its peers – has taken a bearish stance on Trump‘s tariffs.

    In a note published on Sunday, Goldman Sachs analysts, led by chief economist Jan Hatzius, said US consumers had absorbed 22% of tariff costs through June and that figure could rise to 67% if recent tariffs continue on the same trajectory.

    “I think that David should go out and get himself a new economist,” Trump wrote. Hatzius declined to comment.

    In April, Goldman also warned sweeping US tariffs would weigh on global growth and prompt the Federal Reserve to cut interest rates more aggressively than previously expected.

    Last week, the president demanded Intel chief Lip Bu-Tan resign due to his ties to Chinese firms, and has repeatedly targeted Apple boss Tim Cook for making US-sold iPhones outside the country.

    Trump has also taken aim at other Wall Street banks, alleging, without providing evidence, that JP Morgan and Bank of America discriminated against him by refusing his deposits after his first term.

    As the second quarter earnings season progresses, companies have reported a combined financial hit of $13.6bn to $15.2bn between 16 July and 8 August for the full year from Trump‘s tariffs, according to Reuters’ global tariff tracker.

    Continue Reading

  • Trump's unusual Nvidia deal raises new corporate and national security risks, lawmakers and experts say – Reuters

    1. Trump’s unusual Nvidia deal raises new corporate and national security risks, lawmakers and experts say  Reuters
    2. Nvidia and AMD to pay 15% of China chip sale revenues to US government  Financial Times
    3. How the world’s most valuable company got caught in the middle of Trump’s spat with China  CNN
    4. Chip deal: Why the US is taking a cut from China sales  BBC
    5. U.S. Government to Take Cut of Nvidia and AMD A.I. Chip Sales to China  The New York Times

    Continue Reading

  • Trump tells Goldman Sachs CEO to replace economist over tariff predictions

    Trump tells Goldman Sachs CEO to replace economist over tariff predictions

    Goldman Sachs CEO David Solomon participates in an Invest America Roundtable in the State Dining Room at the White House, in Washington, June 9, 2025.

    Evelyn Hockstein | Reuters

    President Donald Trump on Tuesday said Goldman Sachs CEO David Solomon should either replace the bank’s economist or “just focus on being a DJ,” days after Goldman’s chief economist warned that American consumers will pay for an increasing share of new tariffs.

    Trump’s broadside against Solomon — who moonlights as a DJ — came as the president touted what he called “massive” revenue being collected by the federal government due to his tariff policies.

    “Tariffs have not caused Inflation, or any other problems for America, other than massive amounts of CASH pouring into our Treasury’s coffers,” Trump wrote in a Truth Social post.

    Tariff revenue has surged in recent months, rising to nearly $28 billion in July alone, according to the Treasury Department. Inflation, meanwhile, has continued to increase, though the latest data showed consumer prices have accelerated slightly less than expected.

    Trump then wrote, “It has been shown that, for the most part,” companies and foreign governments, rather than consumers, are paying for the tariffs.

    But many economists continue to warn that the full effects of Trump’s tariffs have yet to be felt, and numerous businesses have already said that they will have to raise prices in response to U.S. import duties.

    FILE PHOTO: DJ D-SOL performs during the ‘Safe & Sound’ Drive-In Concert Fundraiser Presented by JAJA Tequila and In The Know Experiences In Partnership with Bumble at Nova’s Ark Project on July 25, 2020 in Water Mill, New York.

    Kevin Mazur | Getty Images

    Solomon and Goldman “refuse to give credit where credit is due,” Trump wrote, claiming they “made a bad prediction a long time ago on both the Market repercussion and the Tariffs.”

    “I think that David should go out and get himself a new Economist or, maybe, he ought to just focus on being a DJ, and not bother running a major Financial Institution,” the president wrote.

    Trump did not name the economist he wants Solomon to replace.

    But Jan Hatzius, the bank’s chief economist since 2011, warned in a research note Sunday that U.S. consumers will end up absorbing an increasing share of the cost of Trump’s tariffs.

    Read more CNBC politics coverage

    “Our estimates imply that US consumers had absorbed 22% of tariff costs through June but that their share will likely rise to 67% by October if the later tariffs have the same impact over time as the earliest tariffs,” Hatzius and other Goldman researchers wrote.

    Trump has also repeatedly postponed many of his most severe tariffs, delaying when their possible economic impacts on U.S. consumers will be felt.

    His global “reciprocal” tariffs, unveiled in early April, were quickly put on pause and took effect in an altered state just last week. And Trump’s tariffs on Chinese goods, which scraped as high as 145% at their peak, have been pared back to 30% since May.

    A Goldman spokesperson declined to comment on Trump’s social media post.

    Continue Reading

  • US deficit grows to $291 billion in July despite tariff revenue surge – Reuters

    1. US deficit grows to $291 billion in July despite tariff revenue surge  Reuters
    2. US July Tariff Revenue Jump Fails to Halt Wider Budget Deficit  Bloomberg
    3. US July budget deficit up 20% year-over-year despite record Trump tariff income  The Washington Post
    4. U.S. Federal Budget Balance Swings to Deeper Deficit, Undermining USD  Investing.com
    5. US federal budget deficit $-291.0 billion versus -$215.0 billion expected  investingLive

    Continue Reading

  • Key European plastics recycling projects scrapped

    Key European plastics recycling projects scrapped

     

    Borealis, Dow, and Neste separately have decided to drop plans for major plastics recycling plants in Europe. The moves add to the spate of plastics recycling plant closures and bankruptcies that have taken place in the region due to plentiful, cheaper virgin plastic undercutting the price of recycled plastic.

    Borealis has put on hold its plan to open a 60,000-metric-ton-(t)-per-year polyolefin mechanical recycling plant in Schwechat, Austria. The Austrian firm had aimed to open the plant by year-end. “A detailed evaluation of the project revealed that in the current market environment the plant would not meet the expected performance targets,” the company tells C&EN in an email.

    Meanwhile, Dow has ditched its plan, announced in 2022, to build a 120,000-t-per-year plant to chemically recycle mixed plastic waste in Böhlen, Germany. The recycling facility was due to deploy Mura Technology’s Hydro-PRT technology, which uses supercritical steam to crack polymer bonds in plastics to form oil.

    It follows Dow’s decision in July to permanently close its ethylene cracker and associated petrochemical facilities in Böhlen in 2027. Oils from the proposed plastics recycling plant would have been used as feedstock in the cracker. Dow says it is closing the cracker because of high operating costs in Europe, including the high cost of energy.

    Separately, Neste and Belgian plastics supplier Ravago Manufacturing have halted plans to jointly build and operate a 55,000-t-per-year plastics-to-chemicals recycling plant in Vlissingen, the Netherlands. The plant would have used a pyrolysis technology developed by the US firm Alterra Energy.

    The industry group Plastics Recyclers Europe has been warning about unfair competition for European plastics recyclers for more than a year. The group sent a letter to all European Union member governments in May stating that the sector “is facing a deepening crisis that requires political action.” Prices for virgin materials remain much lower, demand for recycled content is weak, and third-country—including Chinese—competition is intensifying, the group states.

    Europe produces more than 20 million t per year of ethylene, a key raw material for polymers. The region also recycles about 10 million t of plastic each year. Recycling plastic mechanically saves about 2.5 t of carbon dioxide for each 1 t of plastic produced compared with the production of virgin plastic from oil, according to European recycling association EuRIC.

    Continue Reading

  • Exxon could invest as much as $21.7 billion if it finds oil, gas in Trinidad, energy minister says – Reuters

    1. Exxon could invest as much as $21.7 billion if it finds oil, gas in Trinidad, energy minister says  Reuters
    2. Exxon Mobil may invest up to $21.7 billion in Trinidad and Tobago By Investing.com  Investing.com
    3. ExxonMobil to explore seven ultra-deep blocks off Trinidad’s east coast  MSN
    4. Trinidad awards deepwater blocks to Exxon, could see $21.7 billion investment, minister says  MarketScreener
    5. Exxon could invest up to $21.7B if it finds reserves in Trinidad, Reuters says  TipRanks

    Continue Reading

  • CrowdStrike Named the Only Leader & Outperformer in 2025 GigaOm SSPM Radar Report

    CrowdStrike Named the Only Leader & Outperformer in 2025 GigaOm SSPM Radar Report

    CrowdStrike recognized for delivering the most innovative and complete platform for SaaS security, earning the highest scores in Key Features and Business Criteria among all evaluated vendors

    AUSTIN, Texas – August 12, 2025 – CrowdStrike (NASDAQ: CRWD) today announced it is the only vendor named both a Leader and an Outperformer in the 2025 GigaOm Radar Report for SaaS Security Posture Management (SSPM). The report recognized CrowdStrike as the most innovative and complete Platform Play, with the highest scores among all vendors in Key Features and Business Criteria. CrowdStrike earned perfect 5/5 scores across critical evaluation areas, including SaaS Support, Policy Management, Third-Party Risk Assessment, Identity Threat Detection and Response, Enterprise Security Infrastructure Integration, Scalability, Cost, and Ecosystem.

    This recognition underscores the competitive advantage of CrowdStrike’s unified approach to SaaS security, securing every identity – human, non-human, and AI agent – to stop SaaS breaches and prevent cross-domain attacks. GigaOm highlighted that “CrowdStrike’s single-platform architecture is comprehensive, consolidating SSPM, SaaS DLP, cloud security, identity security, and endpoint protection into a single console, enabling automated, real-time policy responses to swiftly stop attacks.”

    Adversaries increasingly exploit trusted identities to infiltrate organizations undetected, making SaaS environments a top target. With hundreds of SaaS applications in use across enterprises, even minor misconfigurations or excessive permissions create entry points for infiltration and lateral movement. At the same time, the explosion of AI agents in SaaS environments is rapidly expanding the attack surface, with more identities holding persistent, high-risk privileges that adversaries can exploit across identity, endpoint, and cloud systems. To address this emerging risk, CrowdStrike recently expanded Falcon Shield support for OpenAI’s ChatGPT Enterprise Compliance API, enabling visibility and governance over autonomous GPT-based agents like Codex and custom GPTs.

    The AI-native CrowdStrike Falcon® platform delivers the unified protection organizations need to secure this modern threat landscape. CrowdStrike Falcon® Shield delivers complete SaaS Security Posture Management, protecting identities, configurations, and data across SaaS applications. Combined with Falcon® Identity Protection and Falcon® Cloud Security, CrowdStrike secures every human and non-human identity – from initial access to privilege escalation and lateral movement – across SaaS, cloud, and on-prem environments.

    CrowdStrike Falcon platform differentiators recognized by GigaOm include:

    • Complete SaaS Visibility: GigaOm emphasized that Falcon Shield discovers SaaS applications and provides “visibility into SaaS threats, including misconfigured apps, excessive permissions, identity compromise, and unauthorized data access,” with over 175 pre-built integrations. 
    • Automated Threat Response: GigaOm highlighted Falcon® Fusion, CrowdStrike’s no-code SOAR engine, for delivering “automated, real-time policy responses,” such as “disabling users or revoking OAuth app access” to contain threats before they escalate.
    • GenAI and Autonomous Agent Control: CrowdStrike provides comprehensive protection for GenAI, AI agents, and embedded AI tools in SaaS environments. GigaOm noted that CrowdStrike is enhancing these capabilities through Charlotte AI, with “GenAI tools that can monitor SaaS applications, enforce standards, manage AI settings to prevent data leakage, and identify shadow AI apps.”
    • Power of the Platform: GigaOm noted that CrowdStrike “delivers a comprehensive platform for those wishing to consolidate SSPM into a broader stack, including endpoint management, ITDR, and other SaaS-related security disciplines, all of which can be covered by the extensive Falcon platform.”


    “Modern attacks frequently start with adversaries exploiting fragmented identity controls across SaaS, cloud, and endpoint environments to gain access, escalate privileges, and move laterally, often without detection,” said Elia Zaitsev, chief technology officer at CrowdStrike. “SaaS has become one of the most exposed and least governed layers of the enterprise. Attempting to secure it in isolation leaves gaps adversaries can exploit. Organizations need a unified platform that correlates identity, configuration, and behavioral signals across security domains to deliver real-time protection. GigaOm’s recognition validates CrowdStrike’s leadership in delivering that platform purpose-built to protect every identity across the modern attack surface.”

    To learn more about the 2025 GigaOm Radar Report for SSPM, visit here and read our blog.

    About CrowdStrike

    CrowdStrike (NASDAQ: CRWD), a global cybersecurity leader, has redefined modern security with the world’s most advanced cloud-native platform for protecting critical areas of enterprise risk – endpoints and cloud workloads, identity and data.

    Powered by the CrowdStrike Security Cloud and world-class AI, the CrowdStrike Falcon® platform leverages real-time indicators of attack, threat intelligence, evolving adversary tradecraft and enriched telemetry from across the enterprise to deliver hyper-accurate detections, automated protection and remediation, elite threat hunting and prioritized observability of vulnerabilities.

    Purpose-built in the cloud with a single lightweight-agent architecture, the Falcon platform delivers rapid and scalable deployment, superior protection and performance, reduced complexity and immediate time-to-value.

    CrowdStrike: We stop breaches.

    Learn more: https://www.crowdstrike.com/

    Follow us: Blog | X | LinkedIn | Facebook | Instagram

    Start a free trial today: https://www.crowdstrike.com/free-trial-guide/

    © 2025 CrowdStrike, Inc. All rights reserved. CrowdStrike and CrowdStrike Falcon are marks owned by CrowdStrike, Inc. and are registered in the United States and other countries. CrowdStrike owns other trademarks and service marks and may use the brands of third parties to identify their products and services.

    Media Contact

    Jake Schuster

    CrowdStrike Corporate Communications

    press@crowdstrike.com


    Continue Reading

  • Elon Musk threatens Apple with lawsuit over OpenAI, sparking Sam Altman feud | Elon Musk

    Elon Musk threatens Apple with lawsuit over OpenAI, sparking Sam Altman feud | Elon Musk

    Elon Musk has threatened legal action against Apple on behalf of his artificial intelligence startup xAI, accusing the iPhone maker of favoring OpenAI and breaching antitrust regulations in managing the rankings in its App Store. The posts elicited snide responses from Sam Altman, the OpenAI CEO, and began a spat between the two former business partners on X.

    “Apple is behaving in a manner that makes it impossible for any AI company besides OpenAI to reach #1 in the App Store, which is an unequivocal antitrust violation. xAI will take immediate legal action,” Musk said in a post on X.

    In a post earlier that day, he wrote: “Hey @Apple App Store, why do you refuse to put either X or Grok in your ‘Must Have’ section when X is the #1 news app in the world and Grok is #5 among all apps? Are you playing politics?”

    OpenAI’s ChatGPT currently holds the top spot in the App Store’s “Top Free Apps” section in the US, while xAI’s Grok ranks fifth. Apple has a partnership with OpenAI that integrates ChatGPT into iPhones, iPads and Macs. Apple and xAI did not provide comment.

    Altman responded to Musk on X: “This is a remarkable claim given what I have heard alleged that Elon does to manipulate X to benefit himself and his own companies and harm his competitors and people he doesn’t like.” Musk has bent X’s algorithmic recommendations to favor his own tweets, according to multiple reports.

    Altman and Musk founded OpenAI together in 2015, but Musk left the startup and rescinded funding in 2018 after proposing to take it over, a petition other executives rebuffed. Musk has since sued the company twice over its planned transition to a for-profit enterprise, alleging “deceit of Shakespearean proportions”. Altman has cast Musk as a bitter and petty ex-partner who was jealous of the company’s success after departing.

    Musk replied to Altman’s tweet: “You got 3M views on your bullshit post, you liar, far more than I’ve received on many of mine, despite me having 50 times your follower count!”

    Altman replied to Musk multiple times, first calling his lack of views a “skill issue”, then “or bots”, and then offered a legal question of his own: “Will you sign an affidavit that you have never directed changes to the X algorithm in a way that has hurt your competitors or helped your own companies? i will apologize if so.”

    Users on X – through the community notes feature – have pointed out that a few apps besides OpenAI have taken the top spot on the App Store this year.

    Chinese AI app DeepSeek reached the No 1 spot on the platform in January, while in July, Perplexity took first place in India’s App Store – both occurring after the OpenAI and Apple partnership struck last year.

    One user asked X’s native AI, Grok, who was right in the feud. The chatbot replied: “Based on verified evidence, Sam Altman is right.”

    skip past newsletter promotion

    Musk’s comments come as regulators and rivals intensify scrutiny of Apple’s control over its App Store.

    Earlier this year, Apple was ordered to pay a fine of €500m ($581.15m) by the EU antitrust enforcer, which said the company’s restrictions prevented developers from steering users outside the App Store.

    The US Department of Justice filed an antitrust lawsuit against Apple in early 2024, accusing the iPhone maker of creating and maintaining “broad, sustained, and illegal” smartphone monopoly.

    Continue Reading

  • Oil Dips in Thin Summer Trading Ahead of Trump-Putin Meeting

    Oil Dips in Thin Summer Trading Ahead of Trump-Putin Meeting

    Oil inched higher as investors weighed President Donald Trump’s deferral of lofty US tariffs on China Photographer: Angel Navarrete/Bloomberg

    Oil slipped as investors weighed US President Donald Trump’s deferral of lofty tariffs on China against possible outcomes from his planned meeting with Russia’s Vladimir Putin.

    West Texas Intermediate dropped near $63 a barrel in muted summer trading, near last week’s two-month low. Trump extended for another 90 days a truce that was set to expire Tuesday. US inflation data, meanwhile, bolstered speculation the Federal Reserve will soon be able to cut interest rates.

    Most Read from Bloomberg

    Absent any major drivers, traders are looking to the summit between Trump and Putin later this week for signs sanctions on the major oil producer will be eased, although the US president on Monday downplayed expectations for a deal to end the war in Ukraine.

    The aggregate trading volume of global benchmark Brent is well below its daily average — suggesting traders are exercising caution as they seek further insight into the oil market’s outlook. Prices are down by more than 8% this month after trade and geopolitical tensions eased, while many analysts anticipate a supply glut later this year.

    Meanwhile, the US government now expects domestic oil production to fall next year, reversing years of output growth. The EIA also estimated the supply glut would increase to 1.7 million barrels a day in 2026. Looking ahead, the International Energy Agency will release its report on Wednesday.

    Most Read from Bloomberg Businessweek

    ©2025 Bloomberg L.P.

    Continue Reading

  • Neutrophil-targeted drug secures first FDA approval for inflammatory lung disease

    You have full access to this article via your institution.

    The FDA has approved Insmed’s brensocatib (Brinsupri)— an oral small-molecule inhibitor of dipeptidyl peptidase 1 (DPP1) — for non-cystic fibrosis bronchiectasis. It is the first drug specifically approved to treat this inflammatory lung disease, which affects an estimated 350,000–500,000 people in the USA.

    “The unmet need is massive,” says James Chalmers, a respiratory clinician scientist at the University of Dundee who led the clinical trials of brensocatib.

    Insmed’s first-in-class brensocatib could command annual sales of over US$4 billion by 2031, show consensus sales estimates on the Cortellis database. Insmed bought brensocatib from AstraZeneca in 2016 for $160 million.

    Bronchiectasis is a chronic, progressive immune-mediated disease that causes excessive mucus production, persistent cough and widening of the airways — impairing lung function. Recurrent exacerbations lead to hospitalization in many patients. Until now, treatment involved physical therapy to promote mucus clearance and antibiotics to tackle associated respiratory infection.

    Brensocatib is the first drug to target neutrophils, innate immune cells that home to sites of infection where they engulf pathogens, produce cytokines to recruit other immune cells and release antimicrobial peptides called neutrophil serine proteases (NSPs). Over-activation of neutrophils and excessive NSP production drives bronchiectasis as well as other inflammatory diseases.

    The DPP1 protease activates NSPs during neutrophil maturation in the bone marrow. By inhibiting DPP1, brensocatib disarms NSPs while sparing other effector functions of neutrophils that are needed to fight infections.

    “Brensocatib now gives you the opportunity to address the underlying disease,” says Martina Flammer, Chief Medical Officer at Insmed. “It is a game-changer.”

    In a pivotal trial in 1,721 patients who had experienced at least two exacerbations in the past year, daily brensocatib (10 mg or 25 mg) for 1 year met the primary end point, cutting the annualized rate of exacerbations by 20% versus placebo. In the high-dose group, the rate of decline in lung function was slowed to a level in line with normal ageing. Longer studies are needed to test whether the benefit to lung function persists. The drug was generally safe and well-tolerated, with no effect on the rate of infection.

    Over 20 years ago, researchers showed that DPP1-knockout mice were protected against inflammatory arthritis. But a rare genetic condition in humans who lack DPP1 dampened industry interest in the target, as these individuals have substantial abnormalities of the skin and teeth. GSK’s irreversible DPP1 inhibitor GSK2793660 also caused skin abnormalities in a phase II bronchiectasis trial and was discontinued.

    Brensocatib is a reversible covalent inhibitor that seems to have hit a sweet spot in DPP1 inhibition. Brensocatib was associated with hyperkeratosis, a thickening of the skin’s outer layer, in some patients in its phase III trial, but this was mostly mild and only led to treatment discontinuation in one patient.

    A handful of other DPP1 inhibitors are in development, including two candidates in phase III trials for bronchiectasis. Drug developers are also looking at other inflammatory indications with strong neutrophilic components for these agents (Table 1).

    “[Brensocatib is] opening up this pathway for potentially other diseases,” says Kevin Mange, Chief Development Officer at Insmed. “I think you’ll see more coming.”

    AstraZeneca retains the rights to brensocatib for asthma and chronic obstructive pulmonary disease (COPD). The company was testing brensocatib in COPD, but removed the drug from its pipeline in 2023. They declined to comment on development plans.

    Continue Reading